Primary outcomes were completed by 85 of 93 patients ( 91.3 percent ) ; the mean parenteral morphine consumption was significantly reduced on postoperative day 1 in the bupivacaine group ( 20.720.1 mg ) compared with 30.019.1 mg in the control group ( p = 0.02 ) .